How the pro

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Intelligence Network • Data Science • AI Research • World News
Published: 2026-09-22T13:31:02.726Z • Permanent link

A growing trend in the global health and wellness industry has come under scrutiny in recent months, with nicotine products like pouches and patches being promoted for cognitive enhancement, stress reduction, improved athletic performance, and much more. This phenomenon has been fueled by the efforts of companies like Altria Group Inc, British American Tobacco, and Japan Tobacco International, which have been aggressively marketing these products to a younger demographic. According to data from Euromonitor International, the global nicotine replacement therapy (NRT) market is expected to reach $13.4 billion by 2025, with pouches and patches accounting for the majority of this growth.

These companies have been touting the benefits of nicotine as a natural performance enhancer, with some even claiming that it can improve mental clarity and focus. However, experts have raised concerns that the scientific evidence supporting these claims is woefully lacking. A review of the literature published in the Journal of the National Cancer Institute found that the majority of studies on nicotine's cognitive effects were methodologically flawed, and that the evidence for its therapeutic benefits was "inconclusive" at best.

Meanwhile, regulatory bodies have been slow to respond to the growing trend. In the United States, the Food and Drug Administration (FDA) has been tight-lipped about its plans to regulate nicotine products, despite the fact that they are now being marketed as dietary supplements. In the European Union, the European Commission has proposed a ban on the sale of flavored e-liquids, but the proposal has yet to be adopted.

The implications of this trend are far-reaching, with significant consequences for the research community, affected companies, and markets. For researchers, the lack of scientific evidence supporting the therapeutic benefits of nicotine is a major concern, as it undermines the validity of their findings and raises questions about the integrity of the research process. According to a survey of researchers conducted by the journal Addiction, 71% of respondents reported feeling "very concerned" about the influence of industry funding on their research.

The lack of regulation in the NRT market also has significant consequences for public health. With the rise of flavored nicotine products, there is a growing risk of nicotine addiction among youth, particularly in countries where e-cigarettes are still relatively rare. According to a report by the World Health Organization (WHO), the number of e-cigarette-related deaths among young people has increased dramatically in recent years, with the US being a major hotbed of concern.

The broader context of this trend is also worth considering. The rise of the NRT market is part of a larger trend towards the commodification of health and wellness, with companies like Altria and British American Tobacco leveraging their existing infrastructure and brand recognition to promote a range of health-related products. This trend is mirrored in the growing popularity of "clean" and "green" products, which promise to improve physical and mental well-being without the need for pharmaceuticals.